Literature DB >> 11156352

Protein S-100beta in brain and serum after deep hypothermic circulatory arrest in rabbits: relationship to perivascular astrocytic swelling.

H Abdul-Khaliq1, S Schubert, G Stoltenburg-Didinger, D Troitzsch, W Böttcher, M Hübler, M Meissler, C Grosse-Siestrop, V Alexi-Meskishvili, R Hetzer, P E Lange.   

Abstract

The aim of this study was to evaluate the relationship between the kinetic patterns of the protein S-100beta, an astroglial cell marker, and its immunohistochemical expression in the brain in rabbits that underwent cardiopulmonary bypass with deep hypothermic circulatory arrest. Fourteen New Zealand rabbits (weight, 3.1+/-0.25 kg) were anaesthetised, intubated and mechanically ventilated. Four animals were not connected to the cardiopulmonary bypass and served as controls. Ten animals were perfused according to a uniform protocol. After systemic cooling, deep hypothermic circulatory arrest was induced for 60 minutes. After reperfusion and rewarming, the animals were weaned from bypass and sacrificed. In the brain, astrocyte reactivity for S-100beta was evaluated immunocytochemically (DPC Immustain) and the serum concentrations of S-100beta were analysed using a commercially available immunoluminometric kit (Byk-Sangtec, Dietzenbach, Germany). In all experimental animals a significant increase of the serum concentration of the protein S-100beta was found immediately after reperfusion and the termination of cardiopulmonary bypass. In comparison with the control animals, increased staining of S-100beta was found in the astroglial cells and swollen astrocytic end-feet in the perivascular regions. There were fewer signs of neuronal cell injury of neurones in the hippocampus structure. In conclusion, astrocytic activation and S-100beta overexpression seems to precede the neurodegeneration following deep hypothermic circulatory arrest. The marked perivascular cell swelling may support the assumption of reperfusion injury of the astroglial cell complex that forms the blood-brain barrier, which may be indicative of the source of the released S-100beta into the blood stream.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156352     DOI: 10.1515/CCLM.2000.180

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

Review 1.  In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro.

Authors:  R F Haseloff; I E Blasig; H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  The role of EEG recordings in children undergoing cardiac surgery for congenital heart disease.

Authors:  Sascha Meyer; Martin Poryo; Mohammed Shatat; Ludwig Gortner; Hashim Abdul-Khaliq
Journal:  Wien Med Wochenschr       Date:  2017-06-28

3.  Mood disorders are glial disorders: evidence from in vivo studies.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Julia Sacher; Johann Steiner; Ingolf E Blasig; Karsten Mueller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-05-27

4.  Extracranial sources of S100B do not affect serum levels.

Authors:  Nancy Pham; Vincent Fazio; Luca Cucullo; Qingshan Teng; Peter Biberthaler; Jeffrey J Bazarian; Damir Janigro
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

5.  Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.

Authors:  Byong-Su Jang; Hyeran Kim; Shinn-Won Lim; Ki-Won Jang; Doh-Kwan Kim
Journal:  Psychiatry Investig       Date:  2008-09-30       Impact factor: 2.505

6.  Time-Dependent Changes in the Serum Levels of Neurobiochemical Factors After Acute Methadone Overdose in Adolescent Male Rat.

Authors:  Leila Ahmad-Molaei; Mahsa Pourhamzeh; Reza Ahadi; Fariba Khodagholi; Hossein Hassanian-Moghaddam; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2020-07-25       Impact factor: 5.046

7.  Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.

Authors:  Daniel-Paolo Streitbürger; Katrin Arelin; Jürgen Kratzsch; Joachim Thiery; Johann Steiner; Arno Villringer; Karsten Mueller; Matthias L Schroeter
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 8.  Serum S100B represents a new biomarker for mood disorders.

Authors:  Matthias L Schroeter; Julia Sacher; Johann Steiner; Peter Schoenknecht; Karsten Mueller
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.